Does very low HDL-C with normal triglycerides indicate impaired HDL production or maturation?

Low HDL cholesterol (HDL-C) levels occurring in the presence of normal triglycerides (TG) represent a distinct metabolic phenotype. In standard clinical presentations of low HDL, such as metabolic syndrome, the primary driver is the exchange of TG into the HDL core, which leads to rapid particle clearance. When TG levels are normal, this pathway is less active, shifting the diagnostic focus toward defects in the synthesis or maturation of the HDL particle itself.

Clinical and Mechanistic Evidence

Research into the kinetics of lipid metabolism differentiates between TG-driven depletion and primary HDL deficiencies.

• Absence of TG-driven remodeling: In hypertriglyceridemia, Cholesterol Ester Transfer Protein (CETP) facilitates the exchange of triglycerides into HDL particles. These TG-rich particles are hydrolyzed by hepatic lipase, making them small and unstable, leading to rapid renal clearance. When TGs are in the normal range (e.g., <150 mg/dL), this specific depletion mechanism is not the primary cause of low HDL.
• Impaired maturation (LCAT deficiency): Lecithin-cholesterol acyltransferase (LCAT) is critical for converting nascent, discoidal HDL into mature, spherical HDL by esterifying cholesterol. Patients with LCAT deficiency often present with extremely low HDL-C (<10 mg/dL) while maintaining normal triglyceride levels.
• Production and lipidation defects: Mutations in the ABCA1 gene (e.g., Tangier disease) or the APOA1 gene can result in a failure to lipidate apolipoprotein A-I (apoA-I). This prevents the initial formation (production) of nascent HDL particles. While some ABCA1 mutations can present with mild TG elevation, they frequently manifest as severe HDL-C deficiency in an otherwise normal lipid panel.
• Kinetic considerations: While production and maturation defects are significant, kinetic studies (using stable isotope labeling) show that many normotriglyceridemic patients with low HDL-C exhibit a high Fractional Catabolic Rate (FCR) of apoA-I. This indicates that while the cause isn't triglycerides, the end result is often still rapid clearance of the particle rather than just low synthesis rates.

Clinical Implications

For a 74-year-old male, the presence of isolated low HDL with normal triglycerides suggests a different cardiovascular risk profile and potential genetic or specific metabolic origin compared to triglyceride-associated low HDL.

• Diagnostic focus: Clinical evaluation may shift from managing insulin resistance or obesity (common in TG-driven low HDL) to investigating genetic predispositions or specific enzyme deficiencies (LCAT or ABCA1).
• ApoA-I levels: In these cases, measuring apoA-I concentrations can be more informative than HDL-C alone, as it directly reflects the number of circulating particles and the integrity of the production/maturation pathway.

Bottom line

Very low HDL-C with normal triglycerides is a strong clinical indicator of impaired HDL production or maturation (such as LCAT or ABCA1 defects). This phenotype suggests that the low HDL is not merely a secondary consequence of high triglycerides but likely stems from a primary defect in the HDL lifecycle.